Results of the Ninth Scientific Workshop of the European Crohn’s and Colitis Organisation (ECCO): artificial intelligence in IBD: regulatory and methodological considerations
Nurulamin M Noor(Cambridge School), Daniel C. Baumgart(University of Alberta), Bram Verstockt(Universitair Ziekenhuis Leuven), Marco Daperno(A. O. Ordine Mauriziano di Torino), Alessandra Soriano, Shaji Sebastian(University of Hull), Tim Raine(National Health Service), Aart Mookhoek(University of Bern), Alaa El‐Hussuna(Aalborg University Hospital), Mariangela Allocca(Vita-Salute San Raffaele University), Arzu Ensarı, Pieter Sinonquel(KU Leuven), Uri Kopylov(Sheba Medical Center), Isabelle Cleynen(Universidad Carlos III de Madrid), Daniele Noviello(University of Milan), Kapil Sahnan(St. Mark's Hospital), Urko M. Marigorta(Georgia Institute of Technology), Dan Carter(Tel Aviv University), Peter Bossuyt(Imelda Hospital), Jan de Laffolie, Gianluca Pellino(Universitat Autònoma de Barcelona)
Cited by 3
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Crohn's disease
|The Lancet|2012|2.1k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
|Journal of Crohn s and Colitis|2019|1.1k